Evidence map›Paper›PMID 33334426›Full record

ArticleJournal of the American College of Cardiology2020

Prognostic Role of Hepatorenal Function Indexes in Patients With Ebstein Anomaly.

Alexander C Egbe, William R Miranda, Joseph Dearani, Patrick S Kamath, Heidi M Connolly

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Clinical and Imaging Predictors of Poor Prognosis in Ebstein Anomaly.CJC pediatric and congenital heart disease · 2025
    Review
  4. Article
  5. Article
  6. Incidence and correlates of mortality in adults with congenital heart disease of different age groups.International journal of cardiology. Congenital heart disease · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander C EgbeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: egbe.alexander@mayo.edu.
William R MirandaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Joseph DearaniDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Patrick S KamathDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Heidi M ConnollyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Mayo Clinic · US

Funding

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of FallotR01HL158517 · NHLBI · MAYO CLINIC ROCHESTER · PI EGBE, ALEXANDER · 2021 to 2025
$2.9M
Ventricular and Pulmonary Vascular Reserve after the Fontan OperationK23HL141448 · NHLBI · MAYO CLINIC ROCHESTER · PI EGBE, ALEXANDER · 2018 to 2021
$693k
NHLBI NIH HHS K23 HL141448NHLBI NIH HHS R01 HL158517
6 · The paper itself

Abstract

backgroundHepatorenal dysfunction is a risk factor for mortality in patients with chronic tricuspid regurgitation due to acquired heart disease. Ebstein anomaly is the most common cause of primary tricuspid regurgitation in adults with congenital heart disease, but the prevalence and prognostic implications of hepatorenal dysfunction are unknown in this population.

objectivesThe purpose of this study was to determine the risk factors and prognostic implications of hepatorenal dysfunction, as measured primarily by the use of model for end-stage liver disease excluding international normalized ratio (MELD-XI score), as well as looking at other associated factors.

methodsThis was a retrospective study of adults with Ebstein anomaly who received care at Mayo Clinic from 2003 to 2018.

resultsOf 692 patients, the median MELD-XI score was 10.2 (interquartile range: 9.4 to 13.3); 53 (8%) died and 3 (0.4%) underwent heart transplant. MELD-XI was an independent predictor of death/transplant (hazard ratio: 1.32; 95% confidence interval: 1.11 to 2.06; p < 0.001). In the subset of patients with serial MELD-XI scores (n = 416), temporal change in MELD-XI score (ΔMELD-XI) was also a predictor of death/transplant. In the subset of patients who underwent tricuspid valve surgery (n = 344), a post-operative improvement in MELD-XI score (ΔMELD-XI) was associated with improved long-term survival. Impaired right atrial (RA) reservoir strain and elevated estimated RA pressure were associated with worse baseline MELD-XI and ΔMELD-XI scores.

conclusionsHepatorenal dysfunction is a predictor of mortality in Ebstein anomaly, and RA dysfunction and hypertension are hemodynamic biomarkers that can identify patients at risk for deterioration in hepatorenal function and mortality. These data highlight the prognostic importance of noncardiac organ-system dysfunction, and provide complementary clinical risk stratification metrics for management of these patients.

Indexed as

Ebstein AnomalyHeart TransplantationHepatic InsufficiencyRenal InsufficiencyTricuspid Valve InsufficiencyAdultFemaleHumansInternational Normalized RatioKidney Function TestsLiver Function TestsMalePrognosisProportional Hazards ModelsRisk FactorsSeverity of Illness IndexEbstein anomalyhepatorenal dysfunctionmortality

Identifiers

PMID33334426
PMCPMC7755072
OpenAlexW3110734469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.